BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Baar MP, de Rooij ER, Smolders KG, van Schijndel HB, Timmermans EC, Bethell R. Effects of apricitabine and other nucleoside reverse transcriptase inhibitors on replication of mitochondrial DNA in HepG2 cells. Antiviral Res. 2007;76:68-74. [PMID: 17628710 DOI: 10.1016/j.antiviral.2007.05.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Moraes Filho AV, Carvalho CJ, Carneiro CC, Vale CR, Lima DC, Carvalho WF, Vieira TB, Silva DM, Cunha KS, Chen-Chen L. Genotoxic and Cytotoxic Effects of Antiretroviral Combinations in Mice Bone Marrow. PLoS One 2016;11:e0165706. [PMID: 27806085 DOI: 10.1371/journal.pone.0165706] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
2 Saitoh A, Haas RH, Naviaux RK, Salva NG, Wong JK, Spector SA. Impact of nucleoside reverse transcriptase inhibitors on mitochondrial DNA and RNA in human skeletal muscle cells. Antimicrob Agents Chemother 2008;52:2825-30. [PMID: 18541728 DOI: 10.1128/AAC.00434-08] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wendelsdorf KV, Song Z, Cao Y, Samuels DC. An analysis of enzyme kinetics data for mitochondrial DNA strand termination by nucleoside reverse transcription inhibitors. PLoS Comput Biol 2009;5:e1000261. [PMID: 19132079 DOI: 10.1371/journal.pcbi.1000261] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
4 Sohl CD, Kasiviswanathan R, Kim J, Pradere U, Schinazi RF, Copeland WC, Mitsuya H, Baba M, Anderson KS. Balancing antiviral potency and host toxicity: identifying a nucleotide inhibitor with an optimal kinetic phenotype for HIV-1 reverse transcriptase. Mol Pharmacol 2012;82:125-33. [PMID: 22513406 DOI: 10.1124/mol.112.078758] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
5 Esposito F, Corona A, Tramontano E. HIV-1 Reverse Transcriptase Still Remains a New Drug Target: Structure, Function, Classical Inhibitors, and New Inhibitors with Innovative Mechanisms of Actions. Mol Biol Int 2012;2012:586401. [PMID: 22778958 DOI: 10.1155/2012/586401] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 6.1] [Reference Citation Analysis]
6 Côté H, Raboud J, Bitnun A, Alimenti A, Money D, Maan E, Costei A, Gadawski I, Diong C, Read S, Shen S, Harrigan P, Burdge D, King S, Forbes J. Perinatal Exposure to Antiretroviral Therapy Is Associated with Increased Blood Mitochondrial DNA Levels and Decreased Mitochondrial Gene Expression in Infants. J INFECT DIS 2008;198:851-9. [DOI: 10.1086/591253] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
7 Ross MJ. Advances in the pathogenesis of HIV-associated kidney diseases. Kidney Int 2014;86:266-74. [PMID: 24827777 DOI: 10.1038/ki.2014.167] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 4.9] [Reference Citation Analysis]
8 Venhoff AC, Lebrecht D, Reuss FU, Heckl-Ostreicher B, Wehr R, Walker UA, Venhoff N. Mitochondrial DNA depletion in rat liver induced by fosalvudine tidoxil, a novel nucleoside reverse transcriptase inhibitor prodrug. Antimicrob Agents Chemother 2009;53:2748-51. [PMID: 19433557 DOI: 10.1128/AAC.00364-09] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
9 Mazzucco CE, Hamatake RK, Colonno RJ, Tenney DJ. Entecavir for treatment of hepatitis B virus displays no in vitro mitochondrial toxicity or DNA polymerase gamma inhibition. Antimicrob Agents Chemother. 2008;52:598-605. [PMID: 18056280 DOI: 10.1128/aac.01122-07] [Cited by in Crossref: 37] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
10 Cihlar T, Ray AS. Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine. Antiviral Res 2010;85:39-58. [PMID: 19887088 DOI: 10.1016/j.antiviral.2009.09.014] [Cited by in Crossref: 243] [Cited by in F6Publishing: 191] [Article Influence: 20.3] [Reference Citation Analysis]
11 Pessayre D, Fromenty B, Berson A, Robin MA, Lettéron P, Moreau R, Mansouri A. Central role of mitochondria in drug-induced liver injury. Drug Metab Rev. 2012;44:34-87. [PMID: 21892896 DOI: 10.3109/03602532.2011.604086] [Cited by in Crossref: 158] [Cited by in F6Publishing: 133] [Article Influence: 15.8] [Reference Citation Analysis]
12 Saitoh A, Fenton T, Alvero C, Fletcher CV, Spector SA. Impact of nucleoside reverse transcriptase inhibitors on mitochondria in human immunodeficiency virus type 1-infected children receiving highly active antiretroviral therapy. Antimicrob Agents Chemother 2007;51:4236-42. [PMID: 17893156 DOI: 10.1128/AAC.00893-07] [Cited by in Crossref: 33] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
13 Cox S, Southby J. Apricitabine – a novel nucleoside reverse transcriptase inhibitor for the treatment of HIV infection that is refractory to existing drugs. Expert Opinion on Investigational Drugs 2009;18:199-209. [DOI: 10.1517/13543780802641337] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
14 Nadanaciva S, Willis JH, Barker ML, Gharaibeh D, Capaldi RA, Marusich MF, Will Y. Lateral-flow immunoassay for detecting drug-induced inhibition of mitochondrial DNA replication and mtDNA-encoded protein synthesis. Journal of Immunological Methods 2009;343:1-12. [DOI: 10.1016/j.jim.2008.12.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
15 Nagiah S, Phulukdaree A, Chuturgoon A. Mitochondrial and Oxidative Stress Response in HepG2 Cells Following Acute and Prolonged Exposure to Antiretroviral Drugs: NRTIS: MITOCHONDRIAL AND OXIDATIVE STRESS. J Cell Biochem 2015;116:1939-46. [DOI: 10.1002/jcb.25149] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]